Researchers have identified that the protein CLEC14A disrupts the maturation of bone cells, delaying bone formation. The ...

Researchers have discovered a protein that inhibits the activity of bone-forming cells (osteoblasts) by preventing their ...

Topas Therapeutics today announced positive topline results from its Phase 2a trial evaluating lead candidate, TPM502, in patients with celiac disease. The study data serves as the first clinical ...

PharmAbcine, Inc. (KOSDAQ: 208340), a clinical-stage public company developing next-generation therapeutics to address unmet medical needs, ...

Millions of people around the world rely on coffee and tea to survive the morning – but as well as making our heart rate ...

Keywords: Atherosclerosis, Immune-mediated, Inflammation, Vascular diseases, Immune cells, Endothelial dysfunction, Cardiovascular disease, Innate immunity, Adaptive immunity, Plaque instability, ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...